Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingxin He

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Communications Medicine|May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2026
IL-7R-Enriched Extracellular Vesicles From the Thymus Drive Colitis via Promoting Neutrophil Extracellular Trap FormationYao Liao, Yuheng Liu, Ruibing Yang, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Nature Medicine|March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
JAMA Neurology|July 28, 2024
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, et al.
Brain Communications|May 6, 2024
CSF neurofilament light chain profiling and quantitation in neurological diseasesClaire A Leckey, John B Coulton, Tatiana A Giovannucci, et al.
Nature Medicine|February 21, 2024
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Gemma Salvadó, Suzanne E Schindler, et al.
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Communications Medicine|May 20, 2025
Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trialMitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2026
IL-7R-Enriched Extracellular Vesicles From the Thymus Drive Colitis via Promoting Neutrophil Extracellular Trap FormationYao Liao, Yuheng Liu, Ruibing Yang, et al.
Nature Aging|April 28, 2023
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's diseaseNicolas R Barthélemy, Benjamin Saef, Yan Li, et al.
Nature Medicine|March 31, 2025
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Rama K Koppisetti, et al.
JAMA Neurology|July 28, 2024
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Nicolas R Barthélemy, Gemma Salvadó, et al.
Brain Communications|May 6, 2024
CSF neurofilament light chain profiling and quantitation in neurological diseasesClaire A Leckey, John B Coulton, Tatiana A Giovannucci, et al.
Nature Medicine|February 21, 2024
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid testsNicolas R Barthélemy, Gemma Salvadó, Suzanne E Schindler, et al.
Nature Medicine|November 24, 2022
CSF tau microtubule-binding region identifies pathological changes in primary tauopathiesKanta Horie, Nicolas R Barthélemy, Salvatore Spina, et al.
Research Square|March 18, 2024
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer's DiseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Pageof 5